Skip to main content

Table 1 Direct medical costs (RMB, thousand Yuan) of hospitalization in different H7N9 patients

From: Economic burden and its associated factors of hospitalized patients infected with A (H7N9) virus: a retrospective study in Eastern China, 2013–2014

 

All patients (n = 52)

Mild (n = 4)

Severe (n = 27)

Dead (n = 21)

P *

P **

 

Median (IQR)

Proportion, %, median (IQR)

Median (IQR)

Proportion, %, median (IQR)

Median (IQR)

Proportion, %, median (IQR)

Median (IQR)

Proportion, %, median (IQR)

  

Total fee

122 260 (60 710–310 220)

100

12 790 (3 320–19 750)

100

96 780 (56 780–287 140)

100

228 650 (116 410–549 520)

100

<0.0001

--

Examination

8 420 (2 920–17 320)

5.0 (2.5–10.6)

530 (150–1 510)

4.6 (3.5–9.4)

8 660 (3 840–14 700)

7.3 (3.2–11.6)

13 900 (3 400–21 540)

2.8 (1.6–9.9)

0.011

0.092

Lab testing

15 350 (8 520–35 570)

11.9 (9.1–14.9)

1 910 (290–3 390)

16.3 (7.8–19.4)

14 600 (8 470–27 950)

13.2 (10.2–15.3)

25 530 (11 120–65 980)

9.7 (7.6–11.5)

0.002

0.009

Medication

63 250 (27 420–212 700)

53.5 (40.1–60.1)

8 080 (1 820–10 170)

55.1 (34.8–65.3)

61 130 (21 280–151 040)

55.2 (47.0–59.8)

137 410 (54 290–345 040)

49.3 (38.0–60.6)

0.001

0.868

 Western medication

58 390 (22 050–190 890)

99.7 (90.6–100.0)

3 520 (780–8 890)

83.6 (36.0–95.9)

55 750 (20 950–146 220)

99.7 (94.6–100.0)

137 220 (54 290–345 030)

99.7 (91.1–100.0)

0.001

0.420

 TCMa

340 (10–2 490)

0.3(0 .0–3.4)

300 (20–1 700)

12.5 (2.2–19.5)

330 (10–2 420)

0.3 (0.0–3.3)

350 (10–4 870)

0.3 (0.0–2.5)

0.812

0.358

 Antibiotics

12 880 (5 370–38 210)

20.8 (11.1–36.3)

2 740 (530–4 950)

57.6 (22.4–68.3)

13 260 (5 870–39 200)

31.4 (16.1–39.0)

19 060 (7 650–43 730)

13.0 (8.1–30.5)

0.014

0.018

 Antiviral

1 930 (840–4 130)

2.5 (0.9–7.8)

390 (20–790)

7.5 (1.7–14.2)

1 820 (980–4 140)

2.9 (1.1–8.0)

2 990 (1 390–4 780)

1.2 (0.6–5.7)

0.016

0.333

Glucocorticoids

2 320 (340–8 560)

2.3 (0.4–13.3)

0 (0–1 930)

0.0 (0.0–19.0)

1 140 (270–6 700)

1.3 (0.3–13.6)

4 660 (1 620–22 830)

4.1 (1.6–13.0)

0.002

0.072

Immunoglobulin

13 880 (0–33 400)

10.4 (0.0–24.4)

0

0.0

5 960 (0–39 100)

10.4 (0.0–31.6)

23 040 (8 290–39 780)

17.0 (9.4–21.5)

0.014

0.025

Treating

13 860 (5 610–65 210)

14.8 (8.3–23.8)

120 (70–2 500)

2.9 (0.8–12.9)

8 770 (4 600–32 350)

11.2 (7.7–18.3)

54 450 (16 170–200 570)

22.9 (14.8–29.8)

<0.0001

0.002

Medical Consumables

1 010 (0–16 510)

2.4 (0.0–12.2)

300 (100–2 290)

3.7 (2.2–11.8)

150 (0–6 070)

0.2 (0.0–5.9)

21 630 (0–88 810)

12.6 (0.0–19.1)

0.025

0.020

Sick bed

2 400 (1 340–3 990)

1.4 (0.7–3.2)

320 (1 650–5 260)

4.4 (1.1–14.2)

3 040 (1 430–5 150)

2.1 (1.2–4.3)

2 240 (1 410–3 520)

0.8 (0.5–1.4)

0.021

0.001

Nursing

2 390(790–6 270)

1.5 (0.7–3.3)

340 (160–660)

5.3 (0.9–18.9)

3 170 (1 250–6 620)

2.6 (1.1–4.8)

2 180 (1 490–7 850)

1.3 (0.7–1.5)

0.050

0.033

Other fees

100 (0–810)

0.1 (0.0–1.1)

10 (0–70)

0.1 (0.0–0.3)

310 (70–2 400)

0.4 (0.1–2.0)

60 (0–260)

0.0 (0.0–0.2)

0.022

0.032

  1. *P for fee medians comparisons among patients with different clinical outcomes, using Kruskal-wallis H test
  2. **P for proportion medians comparisons among patients with different clinical outcomes, using Kruskal-wallis H test
  3. aTraditional Chinese Medicines